---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-067785"
form_type: "8-K"
ticker: "TVRD"
cik: "0001346830"
company_name: "Tvardi Therapeutics, Inc."
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:37:17.405414+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Director Shaheen Wirk resigns from Tvardi Therapeutics board, no disagreement cited

## Summary
- Shaheen Wirk resigned from the Board of Directors on July 8, 2025.
- Resignation was not the result of any disagreement with the company.
- Wirk had served as a board member since March 2024 and previously as a special advisor.
- No replacement has been announced as of the filing date.

## SEC filing metadata
- accession: 0001104659-25-067785
- form_type: 8-K
- ticker: TVRD
- cik: 0001346830
- company_name: Tvardi Therapeutics, Inc.
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1346830/000110465925067785/0001104659-25-067785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1346830/000110465925067785/tm2520679d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-067785
- JSON: https://secwatch.observer/filing/0001104659-25-067785.json
- Plain text: https://secwatch.observer/filing/0001104659-25-067785.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.